Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nicole C. Hank, MHSM Neurovitality Arizona, United States of America

Similar presentations


Presentation on theme: "Nicole C. Hank, MHSM Neurovitality Arizona, United States of America"— Presentation transcript:

1 Nicole C. Hank, MHSM Neurovitality Arizona, United States of America
Neuro-V: An all in One Natural Supplement to Improve Nerve Regeneration, Increase Cognitive and Physical Performance and Effects on Neuroprotection Nicole C. Hank, MHSM Neurovitality Arizona, United States of America

2 summary Antioxidants and Nutritional Supplements are not required by FDA for approval Neuropathy is a nerve disorder that does not have a cure Many pharmacological therapies are not efficacious Do not regevenate nerves Academy of Neurology required more forms of therapy

3 Summary Antioxidants and vitamins have a myriad of benefits including disease prevention and management B-Vitamins, Alpha Lipoic Acid, Acetyl-L- Cartinine has many functions and have demonstrated nerve regeneration Neuro-V, a nutritional combined supplement can alleviate pain and symptoms from neuropathy

4 Problems Many pharmacologic therapies have undesired side effects
Do not regenevnate nerves Do not have the ability to provide neuroprotection

5 Problems Antioxidants and vitamins are not FDA approved
Neuro-V has not been in clinical trials Neuro-V is not FDA approved, but is globally available

6 Methods Twenty Four patients with peripheral and small fiber neuropathy were given 1 month supply of Neuro-V as adjunctive therapy Brief Pain Inventory (short form) administered at baseline and at Month 1 Visual Analog Scale was administered at baseline and at Month 1

7 Results Sixty-five percent of patients responded positively
Side effects only seen in 7% of study population 92% of patients remained on Neuro-V after study abated

8 Results Over 400 patients have taken Neuro-V for neuropathy Components of Neuro-V also have the capability of improving cognitive impairment and are neuroprotective Athletes and elderly use Neuro-V prophalically Further studies need to be conducted for effacacy

9 References Bril V, England J, Franklin GM, et al (2011) American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine. Evidence-based guideline. Treatment of painful diabetic neuropathy, Neurology, 77 (6): 603. Chiechio S, Copani A, Nicoletti F, Gereau R (2006). Acety-l-carnitine: a proposed therapeutic agent for painful peripheral neuropathies. Curr Neuropharmacol 4(3): Holmay, M. J., M. Terpstra, L. D. Coles, U. Mishra, M. Ahlskog, G. Oz, et al. (2013) N- acetylcysteine boosts brain and blood glutathione in gaucher and Parkinson diseases. Clin. Neuropharmacol 36:103–106. Javed, S., Petropoulos, I., Alam, U., and Malik, A (2015) Treatment of painful diabetic neuropathy Ther Adv Chronic Dis. Jan; 6(1): 15–28. Kaczor, K. (2010)The Therapeutic Effects of Acetyl-L-Carnitine on Peripheral Neuropathy: A Review of the LiteraturePeripheral neuropathy is nerve conduction disruption that occurs outside of the central nervous system. Natural Medicine Journal. Vol. 2 Issue 8.

10 Conclusions Neuro-V has been demonstrated to be Safe Effective
Neuro-V will continue to be sold globally Neuro-V will expand marketing to athletes and elderly besides neuropathy


Download ppt "Nicole C. Hank, MHSM Neurovitality Arizona, United States of America"

Similar presentations


Ads by Google